StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.06+0.03 (+3.40%)

Close on Nov 13, 2026Market cap $38.26MP/E –Yield –

biote operating margin

Operating margin is operating income as a percentage of revenue.

biote's operating margin for the twelve months ending Sep 30, 2026 was 5.0%. For fiscal 2025 it was 18.5%, against 16.0% the year before. The highest annual figure on record is 24.8% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202518.5%+2.5
FY2024Dec 31, 202416.0%+0.6
FY2023Dec 31, 202315.5%+52.3
FY2022Dec 31, 2022-36.8%−61.6
FY2021Dec 31, 202124.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 20265.7%−11.5
Q2 FY2026Jun 30, 2026-7.9%−30.0
Q1 FY2026Mar 31, 20267.0%−12.7
Q4 FY2025Dec 31, 202514.7%+9.2
Q3 FY2025Sep 30, 202517.2%−6.5
Q2 FY2025Jun 30, 202522.0%+9.4
Q1 FY2025Mar 31, 202519.8%−2.5
Q4 FY2024Dec 31, 20245.6%−6.5
Q3 FY2024Sep 30, 202423.7%+7.0
Q2 FY2024Jun 30, 202412.7%−2.9
Q1 FY2024Mar 31, 202422.3%+4.7
Q4 FY2023Dec 31, 202312.1%−4.4
Q3 FY2023Sep 30, 202316.7%−1.9
Q2 FY2023Jun 30, 202315.6%+222.5
Q1 FY2023Mar 31, 202317.6%−8.7
Q4 FY2022Dec 31, 202216.4%+0.6
Q3 FY2022Sep 30, 202218.6%−6.6
Q2 FY2022Jun 30, 2022-207.0%−236.5
Q1 FY2022Mar 31, 202226.3%–
Q4 FY2021Dec 31, 202115.8%–
Q3 FY2021Sep 30, 202125.3%–
Q2 FY2021Jun 30, 202129.5%–

More biote figures

See a number that looks wrong?